genprowebdirectory
GEN Edge
Latest News
Login
Subscribe
News
Insights
Trends for 2020
Trends for 2021
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Latest News
Login
Subscribe
News
Bioprocessing
Look Out for the Coming New Capacity Crunch
Microbiome
The Microbiome’s Evolution is Shaped by Dispersal Strategies
News
Lack of Vitamin D May Increase Risk of Opioid Addiction, and…
Cell Biology
New Glial Cell Discovery May Lead to Improved Brain Repair and…
Molecular Biology
Study Turns Central Dogma on Its Head
Insights
All
Trends for 2020
Trends for 2021
Bioprocessing
Recurrent Neural Networks Can Boost Upstream Processes
Bioprocessing
Moving Mass Spectrometry to the Bioprocessing Floor
Bioprocessing
New Training Program from U.K. Cell and Gene Therapy Catapult
Bioprocessing
Look Out for the Coming New Capacity Crunch
Topics
Bioprocessing
Cancer
Drug Discovery
Genome Editing
OMICs
Translational Medicine
A-Lists
A-Lists
Top 8 Best-Selling COVID-19 Vaccines and Drugs of Q1 2021
A-Lists
Top 10 Life Sciences Jobs Most in Demand over the Next…
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
A-Lists
Seven Biopharma Trends to Watch in 2021
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
COVID-19 Candidates
COVID-19 Definitely Maybe
COVID-19 Definitely Maybe
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
COVID-19 Definitely Maybe
Alexion Pharmaceuticals – Soliris®
COVID-19 Definitely Maybe
The University of Hong Kong (HKU)
COVID-19 Definitely Maybe
Sanofi and Translate Bio – MRT5500
COVID-19 Definitely Maybe
Amgen and Adaptive Biotechnologies
COVID-19 Definitely Maybe
CytoDyn – Vyrologix™ (leronlimab; PRO-140)
COVID-19 Definitely Maybe
Sinopharm Group (Wuhan Institute of Biological Products) and Chinese Academy of...
COVID-19 Definitely Maybe
APEIRON Biologics – APN01
COVID-19 Definitely Maybe
Inovio Pharmaceuticals and Beijing Advaccine Biotechnology – INO-4800
COVID-19 Definitely Maybe
Phlow
COVID-19 Definitely Maybe
Ascletis Pharma – Ganovo®
COVID-19 Definitely Maybe
Vaxart, Emergent BioSolutions, and Kindred Biosciences – VXA-CoV2-1
COVID-19 Definitely Maybe
Covis Pharma – Alvesco
COVID-19 Definitely Maybe
Athersys – MultiStem®
COVID-19 Definitely Maybe
AstraZeneca – AZD7442
COVID-19 Definitely Maybe
Celularity and Sorrento Therapeutics – CYNK-001
1
2
3
Page 1 of 3
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
